Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

  • 2 of 6

Andrew Hopkins, chief executive officer of Exscientia says that based on validation of the technology, people now see the real potential of artificial intelligence

Andrew Hopkins, chief executive officer of Exscientia, says that one of the key challenges for pharmaceutical companies is not just the technology, it’s combining humans, machines and processes to exploit the new technology

Source  Courtesy of Andrew Hopkins